Ore Pharmaceuticals, Lundbeck deal

Ore (formerly Gene Logic Inc.) disclosed in its 2Q09 earnings that it exercised its option to acquire rights to develop and commercialize an undisclosed compound from H. Lundbeck. The compound, which...